Vivanza Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 515837, "name": "Vivanza Biosci.", "stock_name": "Vivanza Biosci.", "full_name": "Vivanza Biosciences Ltd", "name_url": "stocks-analysis/vivanza-biosci", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "1.94", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "1.94", "mcapval": "8.00 Cr", "mcap": "Micro Cap", "scripcode": 530057, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 67, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE984E01035", "curr_date": "Jul 29, 03:30 PM", "curr_time": "03:42 AM", "last_traded_at": "Jul 29, 03:30 PM IST", "bse_nse_vol": "8.92 k", "exc_status": "Active", "traded_date": "Jul 29, 2026", "traded_date_str": "2026 07 29", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Vivanza Biosciences Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vivanza-biosciences-ltd-4127611", "imagepath": "", "date": "2026-07-29 23:17:04", "description": "The next results date for Vivanza Biosciences Ltd is scheduled for August 1, 2026...." }, { "title": "Vivanza Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-lingering-fundamental-challenges-4091735", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivanzaBioscien_mojoScore_4091735.png", "date": "2026-07-07 08:41:00", "description": "Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 July 2026, driven primarily by a shift in technical indicators. Despite this improvement, the company continues to face significant fundamental headwinds, including operating losses and weak long-term growth prospects, which keep the overall outlook cautious." }, { "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-4080997", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivanzaBioscien_mojoScore_4080997.png", "date": "2026-07-01 08:14:18", "description": "Vivanza Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s micro-cap status, weak long-term growth, and unfavourable technical trends have prompted a reassessment of its investment appeal." }, { "title": "Vivanza Biosciences Ltd Upgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-sell-amid-mixed-financial-and-technical-signals-4058363", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_mojoScore_4058363.png", "date": "2026-06-17 08:17:57", "description": "Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 June 2026, driven primarily by a shift in technical indicators despite ongoing fundamental weaknesses. The micro-cap pharmaceutical and biotechnology company’s Mojo Score rose to 34.0, reflecting a cautious optimism among market analysts amid mixed financial and valuation signals." }, { "title": "Vivanza Biosciences Gains 3.45% Despite Downgrade and 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-gains-345-despite-downgrade-and-52-week-low-4052483", "imagepath": "", "date": "2026-06-13 17:31:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Downgrade to Strong Sell by MarketsMOJO</p>\n <p><strong>3 June:</strong> Stock hits 52-week low of Rs.1.65</p>\n <p><strong>5 June:</strong> Week closes at Rs.1.80, up 3.45% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1.74</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1.80</div><div class=\"stat-change positive\">+3.45%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week High</div..." }, { "title": "Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.52 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-falls-to-52-week-low-amidst-continued-market-pressure-4044124", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_priceRelatedfactors_4044124.png", "date": "2026-06-10 10:37:32", "description": "A sharp decline of 13.14% in a single session has dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.52 on 10 Jun 2026, marking a significant underperformance against its sector and the broader market." }, { "title": "Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.65 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-falls-to-52-week-low-amidst-continued-downtrend-4033748", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_priceRelatedfactors_4033748.png", "date": "2026-06-03 10:36:24", "description": "A sharp decline of 8.84% today dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.65, extending its downward trajectory despite recent positive quarterly results. This drop comes amid broader market weakness, with the Sensex also falling sharply, but the stock’s underperformance remains pronounced." }, { "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-4030156", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_mojoScore_4030156.png", "date": "2026-06-02 08:46:08", "description": "Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This adjustment reflects deteriorating technical indicators, persistent operating losses, and underwhelming long-term financial trends despite recent positive quarterly results." }, { "title": "Vivanza Biosciences Declines 1.69% Amid Mixed Technical Signals and Financial Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-declines-169-amid-mixed-technical-signals-and-financial-challenges-4023469", "imagepath": "", "date": "2026-05-30 17:06:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens steady at Rs.1.77 with no price change</p>\n <p><strong>26 May:</strong> Rating upgraded to Sell by MarketsMOJO on technical improvements</p>\n <p><strong>27 May:</strong> Stock dips 1.13% to Rs.1.75 amid mixed market signals</p>\n <p><strong>29 May:</strong> New 52-week low of Rs.1.74 recorded, closing the week down 1.69%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1.77</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div..." } ], "total": 202, "sid": "515837", "stock_news_url": "https://www.marketsmojo.com/news/vivanza-biosciences-515837" }, "announcements": [ { "caption": "Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June 2026.", "datetime": "28-Jul-2026", "details": "Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on June 30 2026 2. Take note of the Notice of Disclosure of Interest and Intimation u/s 164 of the Companies Act 2013 3. Take note of Declarations from Independent Directors U/S 149(7) of The Companies Act 2013 4. Any other business with the permission of the chair", "source": "BSE" }, { "caption": "Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "14-Jul-2026", "details": "we hereby declared that statutory auditor of the company M/s Shivam Soni & co Chartered Accountant (FRN: 152477W) have issued an Audit Report with unmodified opinion on the Audited Financial Result of the Company for the Quarter and year ended on 31st March 2026.", "source": "BSE" }, { "caption": "Appointment of Company Secretary and Compliance Officer", "datetime": "09-Jul-2026", "details": "pursuant to regulation 30 of the SEBI(LODR) Regulations 2015 appointmnet of Mr. Vishal Sureshbhai Katarmal as a Company Secretary and Compliance Officer has been approved with effect from 09th July 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "01 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23", "dt": "2023-03-24", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Downgrade to Strong Sell by MarketsMOJO

3 June: Stock hits 52-week low of Rs.1.65

5 June: Week closes at Rs.1.80, up 3.45% for the week

Week HighRead full news article

Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.52 as Sell-Off Deepens

2026-06-10 10:37:32

A sharp decline of 13.14% in a single session has dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.52 on 10 Jun 2026, marking a significant underperformance against its sector and the broader market.

Read full news article

Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.65 as Sell-Off Deepens

2026-06-03 10:36:24

A sharp decline of 8.84% today dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.65, extending its downward trajectory despite recent positive quarterly results. This drop comes amid broader market weakness, with the Sensex also falling sharply, but the stock’s underperformance remains pronounced.

Read full news article

Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-06-02 08:46:08

Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This adjustment reflects deteriorating technical indicators, persistent operating losses, and underwhelming long-term financial trends despite recent positive quarterly results.